Detailed information about the 100 most recent patent applications.
| Application Number | Title | Filing Date | Disposal Date | Disposition | Time (months) | Office Actions | Restrictions | Interview | Appeal |
|---|---|---|---|---|---|---|---|---|---|
| 18916814 | Method of Fitting the Standard Curve to Analyze the Substrate Concentration by Enzyme Catalysis | October 2024 | October 2025 | Abandon | 12 | 2 | 0 | Yes | No |
| 18885977 | APPARATUS AND METHOD FOR LEACHING TOXIC SUBSTANCES FROM INORGANIC BINDER-STABILIZED SOLID WASTE MATERIALS | September 2024 | February 2025 | Allow | 5 | 1 | 0 | No | No |
| 18645161 | SYSTEMS AND METHODS FOR SAMPLE PREPARATION, DATA GENERATION, AND PROTEIN CORONA ANALYSIS | April 2024 | February 2025 | Allow | 10 | 2 | 0 | Yes | No |
| 18603943 | URINARY MICROBIOMIC PROFILING | March 2024 | February 2025 | Allow | 11 | 2 | 1 | No | No |
| 18407278 | SYSTEMS AND METHODS FOR SAMPLE PREPARATION, DATA GENERATION, AND PROTEIN CORONA ANALYSIS | January 2024 | January 2026 | Allow | 24 | 2 | 0 | Yes | No |
| 18405788 | PURIFICATION CHEMISTRIES AND FORMATS FOR SANGER DNA SEQUENCING REACTIONS ON A MICRO-FLUIDICS DEVICE | January 2024 | December 2025 | Abandon | 24 | 0 | 1 | No | No |
| 18543588 | MASS SPECTROMETRIC QUANTITATION ASSAY FOR METABOLITES OF LEFLUNOMIDE | December 2023 | December 2024 | Allow | 11 | 1 | 0 | No | No |
| 18535618 | VITAMIN D METABOLITE DETERMINATION UTILIZING MASS SPECTROMETRY FOLLOWING DERIVATIZATION | December 2023 | February 2025 | Allow | 14 | 1 | 0 | No | No |
| 18241769 | CONTAINER FOR BLOOD VOLUME ASSESSMENT | September 2023 | September 2024 | Allow | 12 | 1 | 0 | No | No |
| 18459087 | SELF-CONTAINED SAMPLING DEVICE FOR PROCESSING WHOLE BLOOD | August 2023 | September 2025 | Allow | 25 | 1 | 1 | No | No |
| 18239748 | BLOOD INDICATOR PANEL | August 2023 | January 2026 | Allow | 29 | 3 | 0 | No | No |
| 18234004 | 3D Nanochannel Interleaved Devices | August 2023 | December 2024 | Allow | 16 | 2 | 0 | No | No |
| 18365674 | SYSTEMS AND METHODS FOR SAMPLE PREPARATION, DATA GENERATION, AND PROTEIN CORONA ANALYSIS | August 2023 | November 2023 | Allow | 4 | 0 | 1 | No | No |
| 18365627 | SYSTEMS AND METHODS FOR SAMPLE PREPARATION, DATA GENERATION, AND PROTEIN CORONA ANALYSIS | August 2023 | April 2024 | Allow | 8 | 1 | 0 | Yes | No |
| 18142153 | METHODS FOR DETECTING DIHYDROXYVITAMIN D METABOLITES BY MASS SPECTROMETRY | May 2023 | April 2024 | Allow | 11 | 1 | 0 | No | No |
| 18131523 | SALIVA SAMPLE TESTING DEVICES, METHODS, AND MOBILE APP | April 2023 | October 2025 | Abandon | 30 | 2 | 1 | No | No |
| 18178288 | SYSTEMS AND METHODS FOR SAMPLE PREPARATION, DATA GENERATION, AND PROTEIN CORONA ANALYSIS | March 2023 | October 2024 | Allow | 20 | 2 | 0 | Yes | No |
| 18008687 | METHOD FOR HIGHLY-SENSITIVE AND RAPID DETECTION OF PESTICIDE RESIDUE BASED ON IMPRINTED METAL-ORGANIC FRAMEWORK PROBE | December 2022 | November 2024 | Abandon | 24 | 1 | 0 | No | No |
| 18059460 | PIPETTE TIP AND USES AND METHODS THEREOF | November 2022 | September 2024 | Allow | 21 | 2 | 0 | No | No |
| 17982377 | COLLAPSIBLE FLUID COLLECTION CONTAINER FOR BLOOD DETECTION AND MEASUREMENT | November 2022 | January 2026 | Allow | 38 | 3 | 0 | No | No |
| 17981299 | SOLID REAGENT CONTAINMENT UNIT, IN PARTICULAR FOR A TRANSPORTABLE MICROFLUIDIC DEVICE FOR SAMPLE PREPARATION AND MOLECULE ANALYSIS | November 2022 | September 2025 | Allow | 34 | 1 | 1 | Yes | No |
| 17997605 | Colorimetric Measurement of Fludioxonil | October 2022 | October 2025 | Allow | 36 | 0 | 0 | No | No |
| 17976610 | DEPARAFFINIZATION OF TISSUE UTILIZING ELECTRIC FIELD | October 2022 | March 2024 | Allow | 17 | 2 | 0 | No | No |
| 17963911 | CONTAINER FOR BLOOD VOLUME ASSESSMENT | October 2022 | May 2023 | Allow | 8 | 1 | 0 | No | No |
| 17960727 | BLOOD INDICATOR PANEL | October 2022 | May 2023 | Allow | 8 | 1 | 0 | No | No |
| 17935896 | DNA DATA STORAGE ON TWO-DIMENSIONAL SUPPORT MATERIAL | September 2022 | November 2025 | Allow | 38 | 3 | 0 | Yes | No |
| 17901286 | METHODS AND SENSORS FOR DETECTION | September 2022 | March 2024 | Allow | 18 | 3 | 0 | No | No |
| 17857757 | SALIVA SAMPLE TESTING DEVICES, METHODS, AND MOBILE APP | July 2022 | August 2023 | Abandon | 13 | 1 | 0 | No | No |
| 17832295 | Open-Cell Foam Environmental Indicator | June 2022 | June 2025 | Abandon | 37 | 4 | 0 | No | No |
| 17832257 | Open-Cell Foam Environmental Indicator | June 2022 | July 2025 | Abandon | 38 | 4 | 0 | No | No |
| 17752394 | ENZYMATIC SAMPLE PURIFICATION | May 2022 | January 2026 | Abandon | 44 | 1 | 0 | No | No |
| 17749720 | BIOCHEMICAL ANALYSIS SYSTEM | May 2022 | November 2023 | Allow | 18 | 2 | 0 | Yes | No |
| 17745551 | MASS SPECTROMETRIC QUANTITATION ASSAY FOR METABOLITES OF LEFLUNOMIDE | May 2022 | September 2023 | Allow | 16 | 1 | 0 | No | No |
| 17744103 | Sample Receiving System | May 2022 | June 2025 | Allow | 37 | 2 | 1 | No | No |
| 17764968 | TRIBOELECTRIC NANOGENERATOR-BASED BIOCHEMICAL DROPLET REACTION DEVICE AND METHOD | March 2022 | April 2023 | Allow | 13 | 1 | 0 | No | No |
| 17764351 | METHODS FOR QUANTIFICATION OF CARBOHYDRATES | March 2022 | February 2025 | Allow | 34 | 1 | 0 | No | No |
| 17697826 | CONTAINER FOR RAPID BLOOD DETECTION AND BLOOD LOSS ASSESSMENT | March 2022 | April 2023 | Allow | 13 | 1 | 0 | No | No |
| 17637972 | FLUID ANALYSES AND SENSOR CONSTRUCTS EMPLOYING HEXASUBSTITUTED BENZENES | February 2022 | May 2025 | Allow | 39 | 0 | 0 | No | No |
| 17633438 | PERACETIC ACID FORMULATION CONCENTRATION DETERMINATION METHOD | February 2022 | January 2026 | Allow | 47 | 3 | 0 | Yes | No |
| 17590944 | MICROFLUIDIC CHIP-BASED, UNIVERSAL COAGULATION ASSAY | February 2022 | August 2023 | Allow | 18 | 1 | 0 | No | No |
| 17584409 | MICROPLATE FOR CONTAINING A PLURALITY OF SAMPLES | January 2022 | September 2025 | Allow | 43 | 2 | 0 | Yes | No |
| 17626897 | Novel Test Kit | January 2022 | June 2025 | Allow | 41 | 2 | 0 | No | No |
| 17557619 | GAS CONCENTRATION DETECTION METHOD, GAS CONCENTRATION DETECTION DEVICE, AND GAS GENERATION SYSTEM | December 2021 | December 2025 | Abandon | 48 | 0 | 2 | No | No |
| 17645013 | TEST PAPER KIT FOR RAPID GRADED QUANTITATIVE DETECTION OF AROMATIC PRIMARY AMINE CONTENT IN ACIDIC SOLUTION AND APPLICATION THEREOF | December 2021 | March 2025 | Abandon | 39 | 1 | 0 | No | No |
| 17618731 | NANO-RHEOLOGICAL BIOMARKERS FOR EARLY AND IMPROVED FOLLOW-UP OF PATHOLOGIES ASSOCIATED TO RBC DEFORMABILITY ALTERATION | December 2021 | December 2025 | Allow | 48 | 2 | 0 | No | No |
| 17615399 | APPARATUS AND METHOD FOR DETERMINING FILMING AMINE CONCENTRATION IN WATER | November 2021 | May 2025 | Abandon | 42 | 1 | 1 | No | No |
| 17506762 | METHOD AND SYSTEM FOR DETECTING A BIOLOGICAL SUBSTANCE BY HYPERSPECTRAL IMAGING | October 2021 | May 2024 | Allow | 31 | 6 | 1 | Yes | No |
| 17507112 | SUBSTRATE ASSEMBLY AND METHOD OF BONDING SUBSTRATES | October 2021 | July 2023 | Allow | 21 | 1 | 0 | No | No |
| 17495989 | Methods and Apparatuses for Spectrophotometric Determination of Contents and Turbidity of a Liquid Sample | October 2021 | September 2025 | Allow | 47 | 1 | 1 | No | No |
| 17469325 | METHOD FOR ANALYZING BIOMATERIALS BASED ON IMAGE ANALYSIS AND PERSONALIZATION DATA | September 2021 | December 2025 | Abandon | 51 | 2 | 1 | No | No |
| 17467256 | Open-Cell Foam Based Pathogen Remediation | September 2021 | April 2025 | Allow | 43 | 2 | 0 | Yes | No |
| 17284360 | Method for Conveying at Least One First Medium Within a Channel System of a Microfluidic Device | August 2021 | January 2026 | Allow | 57 | 2 | 1 | Yes | No |
| 17408298 | VITAMIN D METABOLITE DETERMINATION UTILIZING MASS SPECTROMETRY FOLLOWING DERIVATIZATION | August 2021 | September 2023 | Allow | 25 | 2 | 0 | No | No |
| 17445486 | CHEMICAL SENSOR DEVICE AND METHOD FOR MANUFACTURING THE SAME | August 2021 | June 2025 | Allow | 46 | 2 | 1 | No | No |
| 17396261 | METHOD FOR DETERMINING FREE RADICALS IN CaO-Al2O3 SERIES OXIDE MELTS | August 2021 | June 2025 | Allow | 46 | 1 | 0 | No | No |
| 17393578 | KIT FOR MEASURING MEASUREMENT TARGET SUBSTANCE AND METHOD FOR MEASURING MEASUREMENT TARGET SUBSTANCE | August 2021 | March 2025 | Allow | 43 | 3 | 0 | Yes | No |
| 17382651 | METHODS FOR DETECTING ANALYTES USING A GRAPHENE-BASED BIOLOGICAL FIELD-EFFECT TRANSISTOR | July 2021 | December 2025 | Abandon | 53 | 3 | 0 | No | No |
| 17381810 | FOCUSING AGENTS AND METHODS OF USING SAME | July 2021 | June 2023 | Allow | 23 | 1 | 0 | No | No |
| 17382028 | MAGNETIC CELL CARRIER COMBINED WITH A POWERLESS BIOREACTOR SYSTEM TO CELL AMPLIFICATION KIT | July 2021 | July 2025 | Abandon | 48 | 2 | 0 | No | No |
| 17363657 | LINEARIZED OPTICAL SENSOR CALIBRATION FOR MEASURING CALCIUM | June 2021 | January 2025 | Allow | 42 | 2 | 1 | Yes | No |
| 17350580 | DEVICE FOR DETECTING MISFOLDED PROTEINS AND METHODS OF USE THEREOF | June 2021 | July 2025 | Abandon | 49 | 3 | 1 | Yes | No |
| 17347059 | REMOVING BUBBLES IN A MICROFLUIDIC DEVICE | June 2021 | May 2025 | Allow | 47 | 6 | 0 | Yes | No |
| 17344367 | METHOD TO PREPARE A SAMPLE FOR ATOM PROBE TOMOGRAPHY (APT), PREPARATION DEVICE TO PERFORM SUCH METHOD AND METHOD TO INVESTIGATE A REGION OF INTEREST OF A SAMPLE INCLUDING SUCH PERFORMING METHOD | June 2021 | July 2024 | Abandon | 38 | 2 | 1 | No | No |
| 17311939 | LYSOSOMAL STORAGE DISORDER BIOMARKERS AND METHODS OF USE THEREOF | June 2021 | October 2025 | Abandon | 52 | 1 | 1 | No | No |
| 17298951 | FLUORESCENT COMPOUND FOR DETECTION OF ISOCYANATE SUBSTANCES, PREPARATION METHOD AND USE THEREOF AS TEST-PAPER-TYPE DETECTION PROBE | June 2021 | June 2022 | Allow | 13 | 2 | 0 | Yes | No |
| 17294151 | ANALYSIS METHOD, ANALYSIS APPARATUS, AND ANALYSIS PROGRAM | May 2021 | August 2024 | Allow | 39 | 1 | 0 | No | No |
| 17291690 | RESPONSIVE INTERFERENCE COLORATION | May 2021 | October 2025 | Abandon | 53 | 2 | 0 | No | No |
| 17287620 | METHOD AND APPARATUS FOR CALCULATING DERIVED CETANE NUMBERS | April 2021 | June 2022 | Allow | 13 | 2 | 1 | No | No |
| 17236962 | Determination of Margin in Freshly Resected Tissue Specimens Using Tumor Responsive Tissue Marking Dye | April 2021 | November 2024 | Abandon | 43 | 1 | 0 | No | No |
| 17286448 | CARBOXYLIC ACID-TYPE LIPID, AND LIPID PARTICLE AND LIPID MEMBRANE EACH COMPRISING CARBOXYLIC ACID-TYPE LIPID | April 2021 | February 2025 | Allow | 46 | 2 | 1 | Yes | No |
| 17284764 | METHODS FOR TREATING AND MONITORING PROGRANULIN-ASSOCIATED DISORDERS | April 2021 | October 2025 | Abandon | 54 | 2 | 2 | No | No |
| 17281842 | METHOD TO DETERMINING METAL CATIONS IN WATER | March 2021 | September 2024 | Abandon | 42 | 1 | 0 | No | No |
| 17216523 | SYSTEMS AND METHODS FOR SAMPLE PREPARATION, DATA GENERATION, AND PROTEIN CORONA ANALYSIS | March 2021 | November 2022 | Allow | 20 | 4 | 0 | Yes | No |
| 17207020 | METHODS OF ESTIMATING BLOOD GLUCOSE AND RELATED SYSTEMS | March 2021 | May 2023 | Allow | 26 | 3 | 0 | Yes | No |
| 17193232 | PURIFICATION CHEMISTRIES AND FORMATS FOR SANGER DNA SEQUENCING REACTIONS ON A MICRO-FLUIDICS DEVICE | March 2021 | October 2023 | Allow | 31 | 1 | 0 | No | No |
| 17274080 | DIGITAL ASSESSMENT OF CHEMICAL DIP TESTS | March 2021 | April 2025 | Allow | 50 | 3 | 0 | Yes | No |
| 17181335 | METHOD FOR DETECTING AND MEASURING HEAVY METALS | February 2021 | October 2021 | Allow | 8 | 2 | 1 | Yes | No |
| 17260705 | Multiplexed Sample Plate | January 2021 | May 2024 | Abandon | 40 | 1 | 0 | No | No |
| 17113536 | AQUATIC ENVIRONMENT MONITORING AND DOSING SYSTEMS AND APPARATUSES, AND METHODS AND SOFTWARE RELATING THERETO | December 2020 | July 2024 | Allow | 44 | 2 | 1 | No | No |
| 17112150 | OPTICAL SENSOR AND METHOD OF OPERATING THE OPTICAL SENSOR | December 2020 | April 2024 | Allow | 41 | 3 | 0 | Yes | No |
| 16951626 | FOCUSING AGENTS AND CALIBRATION TRANSPORTABILITY | November 2020 | June 2024 | Allow | 43 | 1 | 1 | No | No |
| 17087169 | APPARATUS AND METHOD FOR MEASURING GLYCATED HEMOGLOBIN | November 2020 | May 2024 | Abandon | 43 | 1 | 1 | No | No |
| 17067296 | METHODS OF MEMBRANE-BASED PROTEOMIC SAMPLE PREPARATION | October 2020 | October 2024 | Abandon | 48 | 3 | 0 | No | Yes |
| 17032658 | 2H TO 1T PHASE BASED TRANSITION METAL DICHALCOGENIDE SENSOR FOR OPTICAL AND ELECTRONIC DETECTION OF STRONG ELECTRON DONOR CHEMICAL VAPORS | September 2020 | August 2023 | Allow | 34 | 2 | 0 | No | No |
| 17006535 | CAP REMOVAL DEVICE AND THROMBELASTOGRAPHY DEVICE HAVING SAME | August 2020 | August 2023 | Allow | 36 | 2 | 0 | No | No |
| 16976546 | FLUORESCENCE SPECTRAL SHAPE ANALYSIS FOR ANALYTE RECOGNITION | August 2020 | March 2025 | Abandon | 55 | 3 | 0 | No | No |
| 16975305 | ALDEHYDE DETECTION AND ANALYSIS USING SURFACE-ENHANCED RAMAN SPECTROSCOPY | August 2020 | July 2023 | Allow | 35 | 3 | 0 | No | No |
| 16998739 | Devices, Systems, and Methods for Aiding in the Detection of a Physiological Abnormality | August 2020 | May 2023 | Abandon | 33 | 2 | 0 | No | No |
| 16969455 | SKINPRINT ANALYSIS METHOD AND APPARATUS | August 2020 | December 2023 | Abandon | 40 | 0 | 1 | No | No |
| 16963428 | TEMPERATURE ADJUSTMENT STAGE | July 2020 | April 2024 | Allow | 45 | 2 | 0 | Yes | No |
| 16648669 | METHOD FOR DETERMINING PHOSPHATE | July 2020 | May 2023 | Allow | 38 | 3 | 0 | Yes | No |
| 16959461 | POLY(DIACETYLENE) SENSOR ARRAYS FOR CHARACTERIZING AQUEOUS SOLUTIONS | July 2020 | September 2023 | Abandon | 39 | 0 | 1 | No | No |
| 16915467 | Reagent Synthesis and Testing Assays to Detect and Quantify Manganese (II) | June 2020 | January 2023 | Allow | 31 | 1 | 0 | Yes | No |
| 16958850 | METHOD OF MEASURING THE ENDOCYTIC VITAMIN D STATUS | June 2020 | May 2024 | Abandon | 47 | 2 | 0 | No | No |
| 16902745 | DEVICE FOR THE CAPTURE AND REMOVAL OF DISEASE MATERIAL FROM FLUIDS | June 2020 | February 2024 | Allow | 44 | 2 | 0 | Yes | No |
| 16898516 | SAMPLE PRELIMINARY SCREENING CHIP, SPECIMEN DETECTING METHOD, AND SCREENING DEVICE | June 2020 | December 2024 | Allow | 54 | 4 | 1 | Yes | No |
| 16891409 | RECOGNITION KITS AND METHODS FOR HARMFUL HEAVY METALS | June 2020 | December 2022 | Allow | 30 | 2 | 0 | Yes | No |
| 16765132 | METHODS AND SENSORS FOR DETECTION | May 2020 | June 2022 | Allow | 25 | 1 | 0 | No | No |
| 16868998 | CHEMICAL INDICATOR SOLUTION, APPARATUS, AND METHOD FOR DETERMINING CONCENTRATION OF A CHEMICAL WITHIN A FLUID SAMPLE | May 2020 | October 2023 | Allow | 41 | 1 | 1 | No | No |
| 16855589 | SOIL-BASED DNA EXTRACTION | April 2020 | March 2025 | Abandon | 59 | 7 | 0 | Yes | No |
This analysis examines appeal outcomes and the strategic value of filing appeals for examiner GERIDO, DWAN A.
With a 50.0% reversal rate, the PTAB reverses the examiner's rejections in a meaningful percentage of cases. This reversal rate is above the USPTO average, indicating that appeals have better success here than typical.
Filing a Notice of Appeal can sometimes lead to allowance even before the appeal is fully briefed or decided by the PTAB. This occurs when the examiner or their supervisor reconsiders the rejection during the mandatory appeal conference (MPEP § 1207.01) after the appeal is filed.
In this dataset, 31.8% of applications that filed an appeal were subsequently allowed. This appeal filing benefit rate is below the USPTO average, suggesting that filing an appeal has limited effectiveness in prompting favorable reconsideration.
✓ Appeals to PTAB show good success rates. If you have a strong case on the merits, consider fully prosecuting the appeal to a Board decision.
⚠ Filing a Notice of Appeal shows limited benefit. Consider other strategies like interviews or amendments before appealing.
Examiner GERIDO, DWAN A works in Art Unit 1797 and has examined 590 patent applications in our dataset. With an allowance rate of 55.1%, this examiner allows applications at a lower rate than most examiners at the USPTO. Applications typically reach final disposition in approximately 40 months.
Examiner GERIDO, DWAN A's allowance rate of 55.1% places them in the 16% percentile among all USPTO examiners. This examiner is less likely to allow applications than most examiners at the USPTO.
On average, applications examined by GERIDO, DWAN A receive 2.45 office actions before reaching final disposition. This places the examiner in the 71% percentile for office actions issued. This examiner issues a slightly above-average number of office actions.
The median time to disposition (half-life) for applications examined by GERIDO, DWAN A is 40 months. This places the examiner in the 23% percentile for prosecution speed. Applications take longer to reach final disposition with this examiner compared to most others.
Conducting an examiner interview provides a +32.1% benefit to allowance rate for applications examined by GERIDO, DWAN A. This interview benefit is in the 80% percentile among all examiners. Recommendation: Interviews are highly effective with this examiner and should be strongly considered as a prosecution strategy. Per MPEP § 713.10, interviews are available at any time before the Notice of Allowance is mailed or jurisdiction transfers to the PTAB.
When applicants file an RCE with this examiner, 19.3% of applications are subsequently allowed. This success rate is in the 19% percentile among all examiners. Strategic Insight: RCEs show lower effectiveness with this examiner compared to others. Consider whether a continuation application might be more strategic, especially if you need to add new matter or significantly broaden claims.
This examiner enters after-final amendments leading to allowance in 28.4% of cases where such amendments are filed. This entry rate is in the 40% percentile among all examiners. Strategic Recommendation: This examiner shows below-average receptiveness to after-final amendments. You may need to file an RCE or appeal rather than relying on after-final amendment entry.
When applicants request a pre-appeal conference (PAC) with this examiner, 53.3% result in withdrawal of the rejection or reopening of prosecution. This success rate is in the 47% percentile among all examiners. Note: Pre-appeal conferences show below-average success with this examiner. Consider whether your arguments are strong enough to warrant a PAC request.
This examiner withdraws rejections or reopens prosecution in 71.4% of appeals filed. This is in the 58% percentile among all examiners. Of these withdrawals, 48.6% occur early in the appeal process (after Notice of Appeal but before Appeal Brief). Strategic Insight: This examiner shows above-average willingness to reconsider rejections during appeals. The mandatory appeal conference (MPEP § 1207.01) provides an opportunity for reconsideration.
When applicants file petitions regarding this examiner's actions, 60.2% are granted (fully or in part). This grant rate is in the 64% percentile among all examiners. Strategic Note: Petitions show above-average success regarding this examiner's actions. Petitionable matters include restriction requirements (MPEP § 1002.02(c)(2)) and various procedural issues.
Examiner's Amendments: This examiner makes examiner's amendments in 5.6% of allowed cases (in the 87% percentile). Per MPEP § 1302.04, examiner's amendments are used to place applications in condition for allowance when only minor changes are needed. This examiner frequently uses this tool compared to other examiners, indicating a cooperative approach to getting applications allowed. Strategic Insight: If you are close to allowance but minor claim amendments are needed, this examiner may be willing to make an examiner's amendment rather than requiring another round of prosecution.
Quayle Actions: This examiner issues Ex Parte Quayle actions in 0.0% of allowed cases (in the 9% percentile). This examiner rarely issues Quayle actions compared to other examiners. Allowances typically come directly without a separate action for formal matters.
Based on the statistical analysis of this examiner's prosecution patterns, here are tailored strategic recommendations:
Not Legal Advice: The information provided in this report is for informational purposes only and does not constitute legal advice. You should consult with a qualified patent attorney or agent for advice specific to your situation.
No Guarantees: We do not provide any guarantees as to the accuracy, completeness, or timeliness of the statistics presented above. Patent prosecution statistics are derived from publicly available USPTO data and are subject to data quality limitations, processing errors, and changes in USPTO practices over time.
Limitation of Liability: Under no circumstances will IronCrow AI be liable for any outcome, decision, or action resulting from your reliance on the statistics, analysis, or recommendations presented in this report. Past prosecution patterns do not guarantee future results.
Use at Your Own Risk: While we strive to provide accurate and useful prosecution statistics, you should independently verify any information that is material to your prosecution strategy and use your professional judgment in all patent prosecution matters.